Shikoku Cancer Center
In research, Shikoku Cancer Center stands highest in Medicine (#8,221 of 10,443 worldwide) and Health Sciences (#10,041 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Oncology and Pulmonary and Respiratory Medicine — Oncology is 16.9× its share of world research.
- World rank, 2022–2025
- #24,116 of 28,054 · #22,218 all time
- Rank in Japan
- #798 of 1,070
- Research works
- 988 ▲ 3% vs 2013–17
- Citations
- 15k 15.4 per fractional work
- Top-10% rate
- 8.9% record average 16.5%
- Open access
- 43% world 28%
What is Shikoku Cancer Center known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #8,221 of 10,443 | 8.6% | 99 | #6412 | |
| Health SciencesDomain | #10,041 of 11,982 | 8.6% | 101 | #8522 |
Each strip is that field’s whole ranked pool, with the notch where Shikoku Cancer Center sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Shikoku Cancer Center specialise in?
Where its research is concentrated relative to its size: Oncology takes 16.9× the share of its output that it takes of world research.
- OncologySubfield · 22.1 works17×
- Pulmonary and Respiratory MedicineSubfield · 25.4 works14×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.5×. Every wedge is a field page.
- Medicine 4.5×
- Biochemistry, Genetics and Molecular Biology 1.6×
- Pharmacology, Toxicology and Pharmaceutics 1.4×
- Immunology and Microbiology 0.8×
- Chemical Engineering 0.8×
- Nursing 0.6×
- Physics and Astronomy 0.6×
- Health Professions 0.4×
- Dentistry 0.3×
- Economics, Econometrics and Finance 0.1×
- Neuroscience 0.1×
- Mathematics 0.1×
- Psychology 0.1×
- Business, Management and Accounting 0.1×
- Computer Science 0.0×
- Arts and Humanities 0.0×
- Social Sciences 0.0×
- Agricultural and Biological Sciences 0.0×
- Engineering 0.0×
- Materials Science 0.0×
Who are the top researchers at Shikoku Cancer Center?
Ranked on the composite score, S Takashima, Toshiyuki Kozuki and Kazuhiro Takehara lead among researchers whose main affiliation is Shikoku Cancer Center.
- 1 S Takashima Japan · #85,663 worldwide 222 citations · 32 works
- 2 Toshiyuki Kozuki Japan · #178,113 worldwide 128 citations · 30 works
- 3 Kazuhiro Takehara Japan · #307,672 worldwide 67 citations · 53 works
- 4 Naoyuki Nogami Japan · #456,512 worldwide 90 citations · 40 works
- 5 Shosuke Moriwaki Japan · #495,277 worldwide 26 citations · 19 works
- 6 Hiroshi Suehisa Japan · #496,266 worldwide 43 citations · 19 works
- 7 Rieko Nishimura Japan · #535,214 worldwide 25 citations · 24 works
- 8 Masaaki Kataoka Japan · #547,006 worldwide 23 citations · 26 works
- 9 Shigemitsu Takashima Japan · #558,292 worldwide 70 citations · 48 works
- 10 Tohru Ishikawa Japan · #578,592 worldwide 35 citations · 19 works
Which keywords describe research at Shikoku Cancer Center?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Clinical Practice Guidelines, Radiotherapy, Prognostic Factors, Clinical Trials, Immunotherapy, Targeted Therapy and Survival Analysis.
- Gene Expression Profiling
- Cervical Cancer
- Cancer Incidence
- Prognostic Markers
- PET Imaging
- Lung Cancer
- EGFR Mutations
- Treatment Guidelines
- Endoscopic Resection
- Quality of Life
- Molecular Characterization
- Genetic Mutations
- Surgical Management
- Tumor Microenvironment
- Adjuvant Therapy
- Epidemiology
- Survival Analysis
- Immunotherapy
- Prognostic Factors
- Clinical Practice Guidelines
- Chemotherapy
- Radiotherapy
- Clinical Trials
- Targeted Therapy
- Neoadjuvant Therapy
- Breast Cancer
- Metastasis
- Genomic Profiling
- Biomarkers
- Radiation Therapy
- Prostate Cancer
- Molecular Subtypes
- Precision Medicine
- ALK Inhibitors
- CT Screening
- Molecular Profiling
- Tumor Staging
- Palliative Treatment
- Gastric Cancer
- Clinical Guidelines
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy21▲ 26×22 topics
- Clinical Practice Guidelines13▲ 21×10 topics
- Radiotherapy12▲ 27×11 topics
- Prognostic Factors11▲ 22×11 topics
- Clinical Trials10▲ 13×7 topics
- Immunotherapy10▲ 12×15 topics
- Targeted Therapy9▲ 35×5 topics
- Survival Analysis8▲ 26×6 topics
- Neoadjuvant Therapy8▲ 28×5 topics
- Epidemiology7▲ 1.57×29 topics
- Breast Cancer7▲ 25×10 topics
- Adjuvant Therapy7▲ 46×2 topics
- Metastasis7▲ 17×9 topics
- Tumor Microenvironment6▲ 12×8 topics
- Genomic Profiling6▲ 52×2 topics
- Surgical Management6▲ 13×7 topics
- Biomarkers6▲ 7.3×9 topics
- Genetic Mutations6▲ 11×10 topics
- Radiation Therapy6▲ 37×4 topics
- Molecular Characterization5▲ 26×4 topics
- Prostate Cancer5▲ 35×4 topics
- Quality of Life5▲ 2.9×15 topics
- Molecular Subtypes5▲ 47×3 topics
- Endoscopic Resection4▲ 39×2 topics
- Precision Medicine4▲ 8.2×4 topics
- Treatment Guidelines4▲ 18×3 topics
- ALK Inhibitors4▲ 60×1 topic
- EGFR Mutations4▲ 60×1 topic
- CT Screening4▲ 51×1 topic
- Lung Cancer4▲ 20×1 topic
- Molecular Profiling4▲ 35×3 topics
- PET Imaging4▲ 20×4 topics
- Tumor Staging4▲ 31×2 topics
- Prognostic Markers4▲ 30×3 topics
- Palliative Treatment4▲ 49×2 topics
- Cancer Incidence3▲ 22×4 topics
- Gastric Cancer3▲ 25×3 topics
- Cervical Cancer3▲ 26×2 topics
- Clinical Guidelines3▲ 9.0×4 topics
- Gene Expression Profiling3▲ 32×2 topics
Which research topics does Shikoku Cancer Center publish most on?
By volume in 2022–2025: Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment, Management of metastatic bone disease and Gastric Cancer Management and Outcomes.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 4 works
- 2 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 4 works
- 3 Management of metastatic bone disease Surgery 3 works
- 4 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 3 works
- 5 Cancer Immunotherapy and Biomarkers Oncology 2 works
- 6 Colorectal Cancer Treatments and Studies Oncology 2 works
- 7 Endometrial and Cervical Cancer Treatments Obstetrics and Gynecology 2 works
- 8 Breast Cancer Treatment Studies Cancer Research 2 works
- 9 Prostate Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 2 works
- 10 Multiple and Secondary Primary Cancers Epidemiology 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Shikoku Cancer Center's research output changed?
Output in 2018–2022 was 3% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Matsuyama
- Ehime University
- Ehime Prefectural Central Hospital
- Matsuyama University
- Matsuyama Red Cross Hospital
- Ehime University Hospital
- Ehime Medical Center
- Matsuyama Shimin Hospital
- National Institute of Technology, Yuge College
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.